Abstract:Objective: To explore metabolic disturbances in nonobese women with polycystic ovary syndrome (PCOS) compared with nonobese healthy controls. Design: Systematic review and meta-analysis. Setting: Not applicable. Patient(s): Nonobese women with PCOS and nonobese healthy controls. Intervention(s): None. Main outcome measure(s): Prevalence of metabolic disturbances including hyperinsulinemia, insulin resistance (IR), impaired fasting glucose (IFG), impaired glucose intolerance (IGT), prediabetes, dyslipidemia, hypercholesterolemia, hypertriglyceridemia, and low high-density lipoprotein (low-HDL), as well as other metabolic outcomes such as type 2 diabetes mellitus (T2DM), hypertension, metabolic syndrome (Mets), myocardial infarction, stroke, cerebrovascular accident, arterial occlusive disease, and coronary heart disease. Result(s): Compared to nonobese controls, nonobese women with PCOS showed a higher prevalence of hyperinsulinemia (odds ratio [OR], 36.27; 95% confidence interval [CI] 1.76-747.12), IR (OR, 5.70; 95% CI 1.46-22.32), IGT (OR, 3.42; 95% CI 1.56-7.52), T2DM (OR, 1.47; 95% CI 1.11-1.93), hypertriglyceridemia (OR, 10.46; 95% CI 1.39-78.56), low-HDL (OR, 4.03; 95% CI 1.26-12.95), and Mets (OR, 2.57; 95% CI 1.30-5.07). No significant difference was observed for IFG, pre-DM, dyslipidemia, hypercholesterolemia, and hypertension. In subgroup analysis, Whites exhibited increased risks of IR, IGT, IFG, T2DM, hypertension, and Mets, whereas no significant metabolic change was found in Asians. No study reported specifically an incidence of myocardial infarction, stroke, cerebrovascular accident, arterial occlusive disease, and coronary heart disease in nonobese women with PCOS. Conclusion(s): Nonobese women with PCOS also suffer from metabolic disturbances and the risk of long-term metabolic complications. Further efforts should be made to elucidate underlying mechanisms and possible interventions in the early phase.

Dyslipidemia involvement in the development of polycystic ovary syndrome

Metabolic disturbances in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis

Association of lipid profile and obesity in patients with polycystic ovary syndrome

Endometrial Abnormality in Women with Polycystic Ovary Syndrome

Dyslipidemia in Relation to Body Mass Index and Insulin Resistance in Chinese Women with Polycystic Ovary Syndrome.

Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome

Integrated lipid metabolomics and proteomics analysis reveal the pathogenesis of polycystic ovary syndrome

Association of Insulin Resistance and Elevated Androgen Levels with Polycystic Ovarian Syndrome (PCOS): A Review of Literature

Differential Lipidomic Characteristics of Children Born to Women with Polycystic Ovary Syndrome

Characterization of the gut microbiota in polycystic ovary syndrome with dyslipidemia

The Importance of Diagnosing the Polycystic Ovary Syndrome

Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycystic Ovary Syndrome

Prevalence, Pattern and Predictors for Dyslipidemia of Chinese Women With Polycystic Ovary Syndrome

Effect of High Fat Diet on Disease Development of Polycystic Ovary Syndrome and Lifestyle Intervention Strategies

Hormonal changes in PCOS

Association of SOGPI in mediating the effect of Phosphatidylcholine on polycystic Ovary Syndrome

Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: Association with PI3K signaling pathway

Multi-system reproductive metabolic disorder: significance for the pathogenesis and therapy of polycystic ovary syndrome (PCOS)

Effects of Immune Cells and Cytokines on the Endometrial Immune Microenvironment in Polycystic Ovary Syndrome

Dysbiosis of Gut Microbiota Associated with Clinical Parameters in Polycystic Ovary Syndrome

The potential role of uric acid in women with polycystic ovary syndrome